Heterocyclic amides and leucotriene antagonistic use thereof
    7.
    发明授权
    Heterocyclic amides and leucotriene antagonistic use thereof 失效
    杂环酰胺和白三烯的拮抗作用

    公开(公告)号:US5234942A

    公开(公告)日:1993-08-10

    申请号:US628787

    申请日:1990-12-17

    摘要: The invention provides a series of novel heterocyclic amides of the formula I in which the group A; CRa can be --CRb.dbd.CRa--, --CHRb--CHRa-- or --N.dbd.CRa--, the amidic group Re.L can be Rd.X.CO.NH, Re.X.CS.NH or Re.NH.CO attached to position 4, 5 or 6 of the benzenoid moiety, z is an acid group selected from the group consisting of carboxy, an acylsulphonamide residue of the formula CO.NH.SO.sub.n Rg and a tetrazolyl residue of the formula II and the radicals Ra, Rb, Rc, Rd, Re, Rf, Rg, Rh, n, X, G.sup.1,Q and G.sup.2 have the meanings defined in the following specification.The compounds of formula I are leukotriene antagonists. The invention also provides pharmaceutically acceptable salts of the formula I compounds; pharmaceutical compositions containing the formula I compounds, or their salts, for use in the treatment of, for example, allergic or inflammatory diseases, or endotoxic or traumatic shock conditions; and processes for the manufacture of the formula I compounds, as well as intermediates for use in such manufacture.

    摘要翻译: 本发明提供一系列式I的新型杂环酰胺,其中A组; CRa可以是-CRb = CRa-,-CHRb-CHRa-或-N = CRa-,酰胺基Re.L可以是Rd.X.CO.NH,Re.X.CS.NH或Re.NH.CO 连接到苯环部分的4,5或6位,z是选自羧基,式CO.NH.SOnRg的酰基磺酰胺残基和式II的四唑基残基的酸基团和基团Ra, Rb,Rc,Rd,Re,Rf,Rg,Rh,n,X,G1,Q和G2具有以下说明书中定义的含义。 式I的化合物是白三烯拮抗剂。 本发明还提供式I化合物的药学上可接受的盐; 含有式I化合物或其盐的药物组合物,用于治疗例如过敏性或炎症性疾病或内毒素性或创伤性休克病症; 以及制备式I化合物的方法以及用于此类制备的中间体。